Patents by Inventor David Lawrence Earnshaw

David Lawrence Earnshaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • dnaB from Staphylococcus aureus
    Patent number: 6420161
    Abstract: The invention provides dnaB polypeptides and polynucleotides encoding dnaB polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing dnaB polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: July 16, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: David Lawrence Earnshaw, Earl William May, Damien McDevitt
  • DnaB of staphylococcus aureus
    Patent number: 6083924
    Abstract: The invention provides dnaB polypeptides and polynucleotides encoding dnaB polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing dnaB polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: March 12, 1998
    Date of Patent: July 4, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: David Lawrence Earnshaw, Earl William May, Damien McDevitt